Ali Raza, MD
Surgical Oncology · Bronx, NYNPI 1922326883
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,200 of the $9,476 with a category attached, or 76.0%. Intuitive Surgical accounts for 95.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $8,174 and has fallen 87.5% since, to $1,025 in 2025.
Across 30 payments — averaging $315.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Amgen$100
- Astellas Pharma US Inc$100
- Johnson & Johnson$81
- Apollo Endosurgery US Inc$51
- Novartis$30
- plus $75 from 4 others
What the payments were for
- Travel & lodging$1,59617%
- Food & beverage$6807%
- Education$7,20076%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 18 | $9,039 |
| Amgen | 1 | $100 |
| Astellas Pharma US Inc | 1 | $100 |
| Johnson & Johnson | 3 | $81 |
| Apollo Endosurgery US Inc | 2 | $51 |
| Novartis | 1 | $30 |
| BD | 1 | $23 |
| CSL Behring | 1 | $21 |
| Shionogi Inc | 1 | $16 |
| AstraZeneca | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$7,000
- Da Vinci Surgical System$1,898
How this compares
$9,476 in reported general payments places this provider in the 85th percentile of 173 surgical oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $31 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Bronx
- John McAuliffeBronx$15K
- Sheldon FeldmanNew York$97K
- Kepal PatelNew York$94K
- Helen CappuccinoBuffalo$70K
- Jose Alberty OllerStaten Island$63K
- Megan WinnerMineola$51K
- George PlitasNew York$39K
- James ParkNew York$28K
- Anna WeissRochester$27K
- Michael LoweNew York$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.